Upcoming HREB Distinguished Lectures

September 26 – 28, 2007
Dr. Lynn C. Hartman

We are pleased to announce Dr. Lynn C. Hartman, the Blanche R. and Richard J. Erlanger Professor of Medical Research, Professor of Oncology Mayo Clinic College of Medicine, as an HREB visiting scholar on September 26 – 28, 2007.  Dr. Hartman's work has focused on predictors of risk for breast and ovarian cancers, evaluation of novel therapeutics for ovarian cancer, and prevention strategies for breast and gynecologic cancers.  Dr. Hartman is a member of professional societies including the American Association for Cancer Research (AACR), the American Association for the Advancement of Science (AAAS), the Society of Gynecologic Oncology (SGO), and Women in Cancer Research (WICR).  Her presentation is entitled Risk Prediction Strategies for Breast Cancer.

Previous HREB Distinguished Lectures

January 2005
Dr. Rudolf Kaaks of the International Agency for Research on Cancer (IARC)

Dr. Kaaks, former head of the Hormones and Cancer research team at International Agency for Research on Cancer and currently at the Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, is a leading expert on steroid hormones and cancer and a co-PI on the European Prospective Investigation Into Cancer and Nutrition Cohort (EPIC) gave an insightful presentation on "Overweight, physical inactivity, and cancer risk: Hormonal mechanisms."  During his visit, he also emphasized the importance of investigating energy balance, exogenous hormones, and genetic susceptibility in future studies to clarify the underlying mechanisms linking obesity to higher cancer risk.

June 2004
Dr. Frank Stanczyk, Professor of Preventive Medicine at the University of Southern California

Dr. Stanczyk is an internationally recognized authority on the metabolism, pharmacokinetics, and measurement of steroid hormones, and he has collaborated extensively on epidemiologic studies with scientists at several cancer centers and universities as well as those at NCI. During his visit, he challenged epidemiologists to consider measuring complete androgen/estrogen profiles and relevant metabolites in serum and tissue particularly using gas chromatography or liquid chromatography-mass spectrometry, tools for peering into the structure of molecules by separating them based on size and charge. He gave a provocative seminar entitled "Measurements of steroid hormones in epidemiologic studies of breast and prostate cancers: What is missing?".